Cytomegalovirus reactivation in intensive care unit patients: Should it be treated?

Clinical Pulmonary Medicine

Volumn 23, Issue 1, 2016, Pages 11-15

  Thomas, Guillemette ^a,b   Chiche, Laurent ^c   Luyt, Charles Edouard ^d,e   Hraiech, Sami ^a,b   Papazian, Laurent ^a,b   Forel, Jean Marie ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Unité de médecine interne Hôpital européen   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

Antiviral treatment; Cytomegalovirus; Herpes virus; Intensive care unit; Virus

Indexed keywords

GANCICLOVIR;

ANTIVIRAL THERAPY; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; INTENSIVE CARE UNIT; LUNG FIBROSIS; MORBIDITY; OUTCOME ASSESSMENT; PATHOGENICITY; PNEUMONIA; RISK FACTOR; VIRUS REACTIVATION;

EID: 84952786002     PISSN: 10680640     EISSN: 15365956     Source Type: Journal    
DOI: 10.1097/CPM.0000000000000114     Document Type: Article

References (48)

1. Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4:725-738.
2. Kim YJ, Boeckh M, Englund JA. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection. Semin Respir Crit Care Med. 2007;28:222-242.
3. Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med. 2009;37:2350-2358.
4. Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: A systematic review. Crit Care. 2009;13:R68.
5. Legoff J, Guérot E, Ndjoyi-Mbiguino A, et al. High prevalence of respiratory viral infections in patients hospitalized in an intensive care unit for acute respiratory infections as detected by nucleic acid-based assays. J Clin Microbiol. 2005;43:455-457.
6. Hodson EM, Craig JC, Strippoli GFM, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2008;2:CD003774.
7. Bone RC. Sir Isaac Newton, sepsis, SIRS and CARS. Crit Care Med. 1996;24:1125-1128.
8. Luyt CE. Virus diseases in ICU patients: A long time underestimated; but be aware of overestimation. Intensive Care Med. 2006;32:968-970.
9. Cohen JI. Cytomegalovirus in the intensive care unit: pathogen or passenger? Crit Care Med. 2009;37:2095-2096.
10. Domart Y, Trouillet JL, Fagon JY, et al. Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest. 1990;97:18-22.
11. Papazian L, Fraisse A, Garbe L, et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology. 1996;84:280-287.
12. Stéphan F, Méharzi D, Ricci S, et al. Evaluation by polymerase chain reaction of cytomegalovirus reactivation in intensive care patients under mechanical ventilation. Intensive Care Med. 1996;22:1244-1249.
13. Kutza AS, Muhl E, Hackstein H, et al. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis. 1998;26:1076-1082.
14. Cook CH, Yenchar JK, Kraner TO, et al. Occult herpes family viruses may increase mortality in critically ill surgical patients. Am J Surg. 1998;176:357-360.
15. Heininger A, Jahn G, Engel C, et al. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med. 2001;29:541-547.
16. Desachy A, Ranger-Rogez S, François B, et al. Reactivation of human herpesvirus type 6 in multiple organ failure syndrome. Clin Infect Dis. 2001;32:197-203.
17. Razonable RR, Fanning C, Brown RA, et al. Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts. J Infect Dis. 2002;185:110-113.
18. Jaber S, Chanques G, Borry J, et al. Cytomegalovirus infection in critically ill patients: Associated factors and consequences. Chest. 2005;127:233-241.
19. Cook CH, Martin LC, Yenchar JK, et al. Occult herpes family viral infections are endemic in critically ill surgical patients. Crit Care Med. 2003;31:1923-1929.
20. von Müller L, Klemm A, Weiss M, et al. Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis. 2006;12:1517-1522.
21. Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413-422.
22. Ziemann M, Sedemund-Adib B, Reiland P, et al. Increased mortality in long-term intensive care patients with active cytomegalovirus infection. Crit Care Med. 2008;36:3145-3150.
23. Chiche L, Forel JM, Roch A, et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med. 2009;37:1850-1857.
24. Bordes J, Maslin J, Prunet B, et al. Cytomegalovirus infection in severe burn patients monitoring by real-time polymerase chain reaction: A prospective study. Burns. 2011;37:434-439.
25. Heininger A, Haeberle H, Fischer I, et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care. 2011;15:R77.
26. Walton AH, Muenzer JT, Rasche D, et al. Reactivation of multiple viruses in patients with sepsis. PLoS One. 2014;9:e98819.
27. Cassir N, Hraiech S, Nougairede A, et al. Outbreak of adenovirus type 1 severe pneumonia in a French intensive care unit, September-October 2012. Euro Surveill. 2014;19:39.
28. Siciliano RF, Castelli JB, Randi BA, et al. Cytomegalovirus colitis in immunocompetent critically ill patients. Int J Infect Dis. 2014;20:71-73.
29. Döcke WD, Prösch S, Fietze E, et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet. 1994;343:268-269.
30. Cook CH, Trgovcich J, Zimmerman PD, et al. Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol. 2006;80:9151-9158.
31. Hummel M, Abecassis MM. A model for reactivation of CMV from latency. J Clin Virol. 2002;25(suppl 2):S123-S136.
32. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-150.
33. Boeckh M, Murphy WJ, Peggs KS. Recent advances in cytomegalovirus: An update on pharmacologic and cellular therapies. Biol Blood Marrow Transplant. 2014;21:24-29.
34. Chilet M, Aguilar G, Benet I, et al. Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit. J Med Virol. 2010;82:1384-1391.
35. von Muller L, Klemm A, Durmus N, et al. Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis. 2007;196:1288-1295.
36. Arase H, Mocarski ES, Campbell AE, et al. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002;296:1323-1326.
37. Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320:1731-1735.
38. Chiche L, Forel JM, Thomas G, et al. Interferon-g production by natural killer cells and cytomegalovirus in critically ill patients. Crit Care Med. 2012;40:3162-3169.
39. Balthesen M, Messerle M, Reddehase MJ. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol. 1993;67:5360-5366.
40. Papazian L, Doddoli C, Chetaille B, et al. A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med. 2007;35:755-762.
41. Min-Oo G, Lanier LL. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection. J Exp Med. 2014;211:2669-2680.
42. Avdic S, McSharry BP, Slobedman B. Modulation of dendritic cell functions by viral IL-10 encoded by human cytomegalovirus. Front Microbiol. 2014;5:337.
43. Cook CH, Zhang Y, Sedmak DD, et al. Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice. Crit Care Med. 2006;34:842-849.
44. Tuxen DV, Wilson JW, Cade JF. Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1987;136: 402-405.
45. Forster MR, Trgovcich J, Zimmerman P, et al. Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice. Antiviral Res. 2010;85:496-503.
46. Forel JM, Martin-Loeches I, Luyt CE. Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro. Intensive Care Med. 2014;40:1945-1949.
47. Danziger-Isakov L, Mark Baillie G. Hematologic complications of anti-CMV therapy in solid organ transplant recipients. Clin Transplant. 2009;23:295-304.
48. Razonable RR. Immune-based therapies for cytomegalovirus infection. Immunotherapy. 2010;2:117-130.